Adenosine Injection Shortage

• • Adenosine intravenous injection, West-Ward, 3 mg/mL, 2 mL vial, 10 count, NDC 00641-6113-10

• • Astellas discontinued Adenoscan in April 2015. Adenoscan is used for diagnostic purposes as an adjunct to thallium-201 myocardial perfusion scintigraphy. Adenocard and generic adenosine products are labeled for use in paroxysmal supraventricular tachycardia.
  • Sagent had adenosine vials on shortage due to increased demand.
  • West-Ward has adenosine injection on shortage due to manufacturing delays.

• • Adenosine intravenous injection, Akorn, 3 mg/mL, 20 mL vial, 1 count, NDC 17478-0544-20
  • Adenosine intravenous injection, Akorn, 3 mg/mL, 30 mL vial, 1 count, NDC 17478-0544-30
  • Adenosine intravenous injection, Pfizer, 3 mg/mL, 20 mL vial, 25 count, NDC 00409-1932-01
  • Adenosine intravenous injection, Pfizer, 3 mg/mL, 30 mL vial, 25 count, NDC 00409-1932-02
  • Adenosine intravenous injection, Sagent, 3 mg/mL, 20 mL vial, 1 count, NDC 25021-0307-20
  • Adenosine intravenous injection, Sagent, 3 mg/mL, 30 mL vial, 1 count, NDC 25021-0307-30
  • Adenosine intravenous injection, Teva, 3 mg/mL, 20 mL vial, 1 count, NDC 00703-8776-01
  • Adenosine intravenous injection, Teva, 3 mg/mL, 30 mL vial, 1 count, NDC 00703-8777-01
  • Adenocard intravenous injection, Astellas, 3 mg/mL, 2 mL prefilled syringe, 10 count, NDC 00469-8234-12
  • Adenocard intravenous injection, Astellas, 3 mg/mL, 4 mL prefilled syringe, 10 count, NDC 00469-8234-14
  • Adenosine intravenous injection, Akorn, 3 mg/mL, 2 mL vial, 10 count, NDC 17478-0542-02
  • Adenosine intravenous injection, Akorn, 3 mg/mL, 2 mL vial, 25 count, NDC 17478-0542-25
  • Adenosine intravenous injection, Fresenius Kabi, 3 mg/mL, 2 mL vial, 10 count, NDC 63323-0651-02
  • Adenosine intravenous injection, Fresenius Kabi, 3 mg/mL, 4 mL vial, 10 count, NDC 63323-0651-04
  • Adenosine intravenous injection, Sagent, 3 mg/mL, 2 mL prefilled syringe, 10 count, NDC 25021-0301-67
  • Adenosine intravenous injection, Sagent, 3 mg/mL, 2 mL vial, 10 count, NDC 25021-0301-02
  • Adenosine intravenous injection, Sagent, 3 mg/mL, 4 mL prefilled syringe, 10 count, NDC 25021-0301-68
  • Adenosine intravenous injection, Sagent, 3 mg/mL, 4 mL vial, 10 count, NDC 25021-0301-04

Estimated Resupply Dates

• • West-Ward has adenosine 3 mg/mL 2 mL vials on back order and the company cannot estimate a release date.
  • All other marketed presentations are available.